Immuneering (NASDAQ:IMRX) Stock Price Expected to Rise, Mizuho Analyst Says
Immuneering (NASDAQ:IMRX – Get Free Report) had its price target boosted by Mizuho from $8.00 to $10.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 261.01% from the company’s previous close. Other equities […]
Immuneering (NASDAQ:IMRX – Get Free Report) had its price target boosted by Mizuho from $8.00 to $10.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 261.01% from the company’s previous close. Other equities […]
